Received Jun 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Missing second and third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 23-year-old male patient who received HBV (Engerix B) for prophylaxis. Previously administered products included Engerix b (received first dose of Engerix b somewhere last June 2024). On an unknown date, the patient did not receive the 2nd dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incomplete course of vaccination (Verbatim: Missing second and third dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-JUN-2025 The pharmacist reported that a patient that received only a first dose of Engerix b somewhere last June twenty-twenty four. The pharmacist wanted some advice about the patient´s schedule for the second and third dose. No specific vaccination date, no vaccine detail and patient demographics were obtained in this call (no initials provided from the Pharmacist´s end in this call). No further information was obtained. Till the time of reporting the patient did not receive the second dose of Engerix b which led to incomplete course of vaccination.